Clinical Trial Results:
Estudio fase II de LY573636 sódico administrado como tratamiento de segunda o tercera línea en pacientes con sarcoma de tejido blando irresecable o metastásico
A Phase 2 Study of LY573636-sodium Administered as Second-line or Third-line Treatment in Patients with Unresectable or Metastatic Soft Tissue Sarcoma
Summary
|
|
EudraCT number |
2007-001402-24 |
Trial protocol |
ES |
Global completion date |
10 Feb 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Jan 2018
|
First version publication date |
19 Jan 2018
|
Other versions |
|
Summary report(s) |
JZAD Approved CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.